Phase I Randomised, Five-period Cross-over Study in Healthy Male and Female Volunteers to Compare the Pharmacokinetics of Tiotropium Delivered From Three Test Products With Two Reference Products

Trial Profile

Phase I Randomised, Five-period Cross-over Study in Healthy Male and Female Volunteers to Compare the Pharmacokinetics of Tiotropium Delivered From Three Test Products With Two Reference Products

Completed
Phase of Trial: Phase I

Latest Information Update: 19 Jul 2016

At a glance

  • Drugs Tiotropium bromide (Primary)
  • Indications Asthma; Chronic obstructive pulmonary disease; Cystic fibrosis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 13 Jul 2016 Status changed from recruiting to completed.
    • 06 Apr 2016 Planned End Date changed from 1 May 2016 to 1 Jun 2016, according to ClinicalTrials.gov record.
    • 06 Apr 2016 Planned primary completion date changed from 1 Mar 2016 to 1 Apr 2016, according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top